PVI
LUCD icon

Pine Valley Investments’s Lucid Diagnostics LUCD Stock Holding History

Pine Valley Investments’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39K Buy
36,483
+2,200
+6% +$2.37K ﹤0.01% 598
2026
Q1 		$39.4K Buy
34,283
+14,487
+73% +$18.4K ﹤0.01% 564
2025
Q4 		$21.6K Sell
19,796
-300
-1% -$335 ﹤0.01% 554
2025
Q3 		$20.3K Buy
20,096
+8,800
+78% +$9.61K ﹤0.01% 555
2025
Q2 		$13K Hold
11,296
– – ﹤0.01% 545
2025
Q1 		$16.8K Buy
+11,296
New +$13.6K ﹤0.01% 542

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Pine Valley Investments's LUCD Position: Q2 2026 in Review

Pine Valley Investments increased its Lucid Diagnostics (LUCD) stake by 6.4% in Q2 2026, buying an estimated $2.37K and bringing the position to 36,483 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Pine Valley Investments first reported a position in LUCD in Q1 2025 and has held it in 6 quarters since. The position peaked at $39.4K in Q1 2026. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Pine Valley Investments held 36,483 shares of Lucid Diagnostics worth $39K as of Q2 2026.
  • Pine Valley Investments bought 2,200 Lucid Diagnostics shares in Q2 2026, an estimated $2.37K.
  • Lucid Diagnostics made up ﹤0.01% of Pine Valley Investments's portfolio in Q2 2026, its #598 holding.
  • Pine Valley Investments first reported a position in Lucid Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • Pine Valley Investments's Lucid Diagnostics position peaked at $39.4K in Q1 2026.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.